ArticleNPJ precision oncology2022

Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients.

Tessa J J de Bitter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.